节点文献

BRDⅡ株风疹减毒活疫苗免疫持久性观察

Immunopersistent of Attenuated Live Rubella Vaccine Prepared with BRD Ⅱ Strain

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 王淑珍韩雅儒王长太董春明华伟湘杜方众张光荣胡洪江李爱云李跃华

【Author】 Wang Shuzhen; Han Yaru; Wang Changtai et al (National Vaccine & Serum Institute, Bei-jing 100024)

【机构】 卫生部北京生物制品研究所!北京100024湖南省常德地区卫生防疫站!常德415000415

【摘要】 应用BRDⅡ株26代、28代和31代风疹减毒活疫苗对风疹血凝抑制(HI)抗体阴性的551名1~6岁儿童进行了免疫效果观察。3批疫苗免局42天抗体阳转率分别为98.0%、96.8%和96.4%,抗体GMT分别为115.1、100.9和94.8,表明BRDⅡ株具有良好的免疫原性。3批疫苗的抗体GMT逐年下降,到第3年分别为34、4、36.9和31.2,但各批间差异无显著意义。免后3年,26代和28代疫苗的抗体阳性率仍保持在95%以上,而31代疫苗的抗体阳性率下降至89.2%,明显低于其它两批疫苗。

【Abstract】 551 children (aged 1~6 years) without HI antibodies to rubella were inmmunized with 3 lots of attenuated live rubella vaccines prepared with the 26th, 28th and 31th passage of BRD Ⅱ strain respectively. The HI antibody positive conversion rates of the children 42 days after being immunized with the 3 lots were 98.0%, 96. 8% and 96. 4%respectively, and the GMTs of them were 115. 1, 100.9 and 94. 8 respectively. The result showed good immunogenicity of BRDⅡ strain. The GMTs were decreased from year to year. They were 34. 4, 36. 9 and 31. 2 respectively at the 3rd year after immunization. However, no significant difference was found among the GMTs of the 3 lots. At the 3rd year,the antibody positive rates of the vaccines prepared with the 26th and 28th passage of BRD Ⅱ strain were still above 95%, but that of the vaccine prepared with the 31th passage was decreased to 89. 2 %, that was signficantly lower than those of the other 2 lots.

  • 【文献出处】 中国生物制品学杂志 ,CHINESE JOURNAL OF BIOLOGICALS , 编辑部邮箱 ,1997年04期
  • 【分类号】R392
  • 【被引频次】3
  • 【下载频次】51
节点文献中: 

本文链接的文献网络图示:

本文的引文网络